Vanguard Group’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.5M Buy
11,716,829
+229,100
+2% +$225K ﹤0.01% 2826
2025
Q1
$16.5M Sell
11,487,729
-228,019
-2% -$328K ﹤0.01% 2592
2024
Q4
$25.8M Sell
11,715,748
-1,327,329
-10% -$2.92M ﹤0.01% 2464
2024
Q3
$21.5M Buy
13,043,077
+2,226,315
+21% +$3.67M ﹤0.01% 2560
2024
Q2
$24M Buy
10,816,762
+1,990,216
+23% +$4.42M ﹤0.01% 2476
2024
Q1
$23.7M Buy
8,826,546
+3,688,796
+72% +$9.89M ﹤0.01% 2519
2023
Q4
$15.4M Buy
5,137,750
+396,388
+8% +$1.19M ﹤0.01% 2709
2023
Q3
$4.65M Buy
4,741,362
+478,097
+11% +$469K ﹤0.01% 3284
2023
Q2
$5.93M Sell
4,263,265
-55,224
-1% -$76.8K ﹤0.01% 3229
2023
Q1
$6.87M Buy
4,318,489
+58,025
+1% +$92.3K ﹤0.01% 3154
2022
Q4
$26.5M Buy
4,260,464
+221,939
+5% +$1.38M ﹤0.01% 2491
2022
Q3
$27.1M Sell
4,038,525
-257,673
-6% -$1.73M ﹤0.01% 2496
2022
Q2
$27.3M Sell
4,296,198
-195,332
-4% -$1.24M ﹤0.01% 2491
2022
Q1
$20.8M Buy
4,491,530
+730,091
+19% +$3.39M ﹤0.01% 2751
2021
Q4
$18.8M Buy
3,761,439
+1,921,196
+104% +$9.61M ﹤0.01% 2871
2021
Q3
$22.2M Sell
1,840,243
-459,745
-20% -$5.54M ﹤0.01% 2812
2021
Q2
$48.6M Sell
2,299,988
-19,125
-0.8% -$404K ﹤0.01% 2388
2021
Q1
$65.1M Sell
2,319,113
-46,194
-2% -$1.3M ﹤0.01% 2167
2020
Q4
$61.5M Buy
2,365,307
+60,960
+3% +$1.58M ﹤0.01% 2096
2020
Q3
$85.7M Sell
2,304,347
-57,306
-2% -$2.13M ﹤0.01% 1764
2020
Q2
$121M Sell
2,361,653
-118,459
-5% -$6.08M ﹤0.01% 1572
2020
Q1
$78.2M Sell
2,480,112
-167,799
-6% -$5.29M ﹤0.01% 1662
2019
Q4
$158M Sell
2,647,911
-20,552
-0.8% -$1.23M 0.01% 1515
2019
Q3
$97.8M Buy
2,668,463
+421,177
+19% +$15.4M ﹤0.01% 1745
2019
Q2
$105M Buy
2,247,286
+489,863
+28% +$22.8M ﹤0.01% 1728
2019
Q1
$70.6M Buy
1,757,423
+59,353
+3% +$2.38M ﹤0.01% 1915
2018
Q4
$78.1M Buy
1,698,070
+48,902
+3% +$2.25M ﹤0.01% 1808
2018
Q3
$73.2M Buy
1,649,168
+99,946
+6% +$4.43M ﹤0.01% 1955
2018
Q2
$60.7M Buy
1,549,222
+64,176
+4% +$2.52M ﹤0.01% 2032
2018
Q1
$107M Buy
1,485,046
+554,565
+60% +$40.1M ﹤0.01% 1679
2017
Q4
$61.3M Buy
930,481
+50,158
+6% +$3.3M ﹤0.01% 1961
2017
Q3
$44.1M Buy
880,323
+124,099
+16% +$6.22M ﹤0.01% 2097
2017
Q2
$35M Buy
756,224
+32,074
+4% +$1.48M ﹤0.01% 2198
2017
Q1
$25.6M Buy
724,150
+123,318
+21% +$4.35M ﹤0.01% 2342
2016
Q4
$7.52M Buy
600,832
+32,629
+6% +$408K ﹤0.01% 2867
2016
Q3
$7.87M Sell
568,203
-243,501
-30% -$3.37M ﹤0.01% 2800
2016
Q2
$8.02M Buy
811,704
+74,928
+10% +$740K ﹤0.01% 2753
2016
Q1
$12.5M Buy
736,776
+10,706
+1% +$181K ﹤0.01% 2495
2015
Q4
$16.2M Sell
726,070
-1,190
-0.2% -$26.5K ﹤0.01% 2399
2015
Q3
$17.2M Buy
727,260
+18,937
+3% +$447K ﹤0.01% 2360
2015
Q2
$57.9M Buy
708,323
+312,003
+79% +$25.5M ﹤0.01% 1855
2015
Q1
$36.7M Buy
396,320
+146,702
+59% +$13.6M ﹤0.01% 2059
2014
Q4
$10.1M Buy
249,618
+90,163
+57% +$3.65M ﹤0.01% 2534
2014
Q3
$3.9M Buy
159,455
+619
+0.4% +$15.1K ﹤0.01% 2966
2014
Q2
$2.52M Buy
158,836
+119
+0.1% +$1.89K ﹤0.01% 3164
2014
Q1
$2.4M Buy
158,717
+22,302
+16% +$337K ﹤0.01% 3141
2013
Q4
$1.88M Buy
136,415
+62,525
+85% +$859K ﹤0.01% 3211
2013
Q3
$1.39M Buy
+73,890
New +$1.39M ﹤0.01% 3273